MedPage Today on MSN
PD-1 inhibitor raises PFS in advanced acral melanoma
First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...
Odejinmi, M. , Thompson, S. and Wastesicoot, D. (2025) Community-Led Transformation of the Housing and Education Systems by York Factory First Nation, Manitoba, Canada. Open Journal of Social Sciences ...
Objective To analyse temporal trends of respiratory infectious diseases (RIDs) in Baiyin City from 2014 to 2023, aiming to explore the epidemiological patterns of these diseases (tuberculosis, scarlet ...
Lexaria Bioscience (LEXX) provides the following additional secondary and exploratory endpoint final results update on its Phase 1b, 12-week ...
A century ago, two oddly domestic puzzles helped set the rules for what modern science treats as "real": a Guinness brewer charged with quality control and a British lady insisting she can taste ...
MIAMI--(BUSINESS WIRE)--$SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today noted that our partner, Akeso, Inc ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive full results from the BaxHTN Phase III trial showed baxdrostat demonstrated a statistically significant and clinically meaningful reduction in mean seated ...
1 Division of Informatics, Clinical Epidemiology, Oregon Health and Science University, Portland, OR, United States 2 Fariborz Maseeh Department of Mathematics and Statistics, Portland State ...
6 German Center for Diabetes Research (DZD), München-Neuherberg, Germany Importance Differences in treatment effects between men and women may have important implications across diverse interventions ...
Between June 8, 2018, and Oct 25, 2022, 2893 women were randomly assigned to induction of labour (n=1447) or standard care (n=1446); the trial was terminated before the target of 4000 participants was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results